Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Report Date: March 26, 2026
Reporting Period: Quarter and fiscal year ended December 31, 2025
This filing serves as a notification that the company issued a press release announcing its financial results for the period ended December 31, 2025. The detailed results are contained in Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the press release (Exhibit 99.1) but are not detailed within the body of this Form 8-K.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the text of this filing. The document solely references the issuance of the results announcement.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release by the company but does not include specific management commentary, forward-looking guidance, or risk factors within this text.
Unusual Items: None disclosed in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 26, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends in the full press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.